MarketFriction

Vijaya Diagnostic Centre Ltd

NSE VIJAYA · BSE 543350 · Healthcare Service Provider
₹1,428.00 -0.67%
NSE close2026-10-01
52 week range848.00 - 1,593.60
Market cap₹15,192 Cr.
P/E81.0
IPO 2021 · +169% since Nifty 500Smallcap 250 Price band 20% Delivery 58.1%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales139133155156183169173188202205219231
Expenses82809295107102104115120119124132
Operating Profit575263617667697482869699
OPM %41%39%41%39%42%40%40%39%41%42%44%43%
Other Income733455576529
Interest6666677789911
Depreciation141516171718192122242425
Profit before tax453544425747475258586471
Tax %25%25%23%25%26%24%26%26%25%26%25%25%
Net Profit342634324235353943434853
EPS in Rs3.262.533.273.064.103.433.403.764.214.204.665.16
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales251293339377462459548681814857
Expenses171184206211259277327408477495
Operating Profit80108133166204182221273337362
OPM %32%37%39%44%44%40%40%40%41%42%
Other Income7101512131419172122
Interest5141515162124273337
Depreciation26404950536257719296
Profit before tax556583112147114159193233251
Tax %37%29%25%24%25%25%25%26%26%
Net Profit3546638511185120144173187
EPS in Rs77.44101.29138.0018.6410.768.2911.6114.0116.8118.23
Dividend Payout %0%0%0%0%9%12%9%14%12%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%17%21%20%
Compounded Profit Growth%14%24%24%
Stock Price CAGR%22%44%48%
Return on Equity%19%18%18%
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital55551010101010
Reserves157203270354458535647789947
Borrowings33146161141183248259320423
Other Liabilities39534641626166155127
Total Liabilities2344064825417138539831,2741,507
Fixed Assets1192592722683705247428651,069
CWIP33109342897035
Investments7369552854139109185228
Other Assets3976146236255163123154174
Total Assets2344064825417138539831,2741,507
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity6291106130158165183224271
Cash from Investing Activity-98-90-31-130-123-110-141-182-174
Cash from Financing Activity-8-7-30-49-31-42-45-52-69
Net Cash Flow-44-646-49413-2-927
Free Cash Flow3231699837409913291
CFO/OP103%101%98%97%97%105%98%97%96%
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days121196881189
Inventory Days242023172213292119
Days Payable176196180142110172184143145
Cash Conversion Cycle-140-165-149-118-81-152-144-114-117
Working Capital Days-41-51-49-26-34-36-29-48-37
ROCE %28%23%27%28%18%20%21%21%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters54.90%54.87%54.06%53.92%53.91%53.91%53.05%52.63%52.60%52.60%52.51%52.51%
FIIs20.68%19.95%20.09%20.08%18.14%17.54%19.36%19.56%18.27%15.10%13.38%11.65%
DIIs18.64%19.82%20.80%21.49%23.45%24.62%23.72%24.07%25.34%28.60%29.93%31.61%
Public5.78%5.36%5.03%4.50%4.49%3.92%3.86%3.73%3.77%3.70%4.17%4.22%
No. of Shareholders72,79566,20466,72462,41562,25860,95266,89162,11558,99457,78462,94667,251

Fundamentals

Market Cap₹ 15,192 Cr.
Current Price₹ 1,475
Stock P/E81.0
Book Value₹ 93.0
ROCE20.5 %
ROE18.3 %
Dividend Yield0.14 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)20%
Compounded Profit Growth (TTM)24%
Consolidated figures.
Valuation
Market capRs 14,656 Cr
Enterprise valueRs 14,927 Cr
P/E (TTM)78.17x
Price to book18.34x
Price to sales17.10x
EV / EBITDA38.85x
EV / EBIT51.80x
EV / sales17.42x
Price to cash flow65.29x
Earnings yield1.28%
Dividend yield0.14%
P/E, 3-year average57.97x
P/B, 3-year average10.06x
P/E, 5-year average53.66x
P/B, 5-year average9.93x
Profitability
Operating margin (excl. other income)40.10%
Operating margin (incl. other income)42.63%
EBITDA margin44.83%
Pre-tax margin29.33%
Net profit margin21.87%
Net margin, latest quarter22.99%
ROE19.75%
ROCE21.61%
ROA12.75%
ROE, 3-year average18.74%
ROCE, 3-year average20.54%
ROA, 3-year average12.16%
ROE, 5-year average21.88%
ROCE, 5-year average23.46%
ROA, 5-year average14.10%
ROIC (approx.)20.05%
Tax rate25.56%
Other income / net worth2.16%
Growth
Sales growth (latest year)24.38%
Profit growth (latest year)21.00%
Sales CAGR, 3 years13.80%
Sales CAGR, 5 years15.00%
Profit CAGR, 3 years9.45%
Profit CAGR, 5 years18.12%
Sales growth QoQ5.29%
Profit growth QoQ10.79%
Sales growth YoY (latest quarter)22.83%
Profit growth YoY (latest quarter)37.60%
Per share
EPS (TTM)Rs 18.27
EPS (latest year)Rs 14.01
EPS (latest quarter)Rs 5.17
EPS, 3-year averageRs 11.30
EPS, 5-year averageRs 12.66
Book value per shareRs 77.86
Sales per shareRs 83.51
Cash flow per shareRs 21.87
Free cash flow per shareRs 8.87
Dividend per share (latest year)Rs 2.00
Dividend per share, 3-year averageRs 1.33
Dividend per share, 5-year averageRs 1.25
Dividends
Dividend payout14.27%
Dividend payout, 3-year average11.65%
Dividend payout, 5-year average11.06%
Efficiency
Asset turnover0.54x
Fixed asset turnover0.79x
Inventory turnover29.32x
Inventory days12 days
Debtor days8 days
Debtors turnover46.16x
Creditor days145 days
Cash conversion cycle-117 days
Working capital days-37 days
Leverage
Total debtRs 320 Cr
Cash and bankRs 49 Cr
Net debtRs 271 Cr
Debt to equity0.40x
Net debt / EBITDA0.70x
Interest coverage7.84x
Current ratio (filing 2026-03-31)2.60x
Quick ratio (filing 2026-03-31)2.56x
Trade payables (filing 2026-03-31)Rs 38 Cr
Owners' fund to total sources62.75%
Debt to assets25.09%
Cash flow
Cash from Operating Activity (latest year)Rs 224 Cr
Cash from Investing Activity (latest year)Rs -182 Cr
Cash from Financing Activity (latest year)Rs -52 Cr
Net Cash Flow (latest year)Rs -9 Cr
Free cash flow (latest year)Rs 91 Cr
FCFE (approx.: FCF + change in debt)Rs 151 Cr
Cash from ops / profit, 5 years1.58x
Sales to cash flow3.04x
Statement figures
Net sales (TTM)Rs 857 Cr
Net sales (latest year)Rs 681 Cr
Sales (latest quarter)Rs 231 Cr
Operating profit excl. other income (latest year)Rs 273 Cr
Operating profit (latest quarter)Rs 99 Cr
Other income (TTM)Rs 22 Cr
EBITDA (TTM)Rs 384 Cr
PBDT (TTM)Rs 347 Cr
Profit before tax (TTM)Rs 251 Cr
Tax (latest year)Rs 49 Cr
Net profit (TTM)Rs 187 Cr
Net profit (latest year)Rs 144 Cr
Net profit (latest quarter)Rs 53 Cr
Depreciation (TTM)Rs 96 Cr
Depreciation (latest quarter)Rs 25 Cr
Interest (TTM)Rs 37 Cr
Cost of goods sold (latest year)Rs 145 Cr
Total expenditure (latest year)Rs 408 Cr
Total income (latest year)Rs 699 Cr
Share capitalRs 10 Cr
ReservesRs 789 Cr
Shareholders' fundsRs 799 Cr
Total assetsRs 1,274 Cr
Net blockRs 865 Cr
Capital work in progressRs 70 Cr
InvestmentsRs 185 Cr
ReceivablesRs 15 Cr
InventoryRs 5 Cr
Other liabilitiesRs 155 Cr
Shares outstanding (crore)10.26
Ownership
Promoter holding52.51% (-0.12 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 78.2 is at the 71th percentile of its own 5.2-year range (median 68.1, low 40.5, high 141.5).
P/B 18.34 is at the 76th percentile (median 15.59).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodVIJAYANifty 50Difference
1 week-6.5%-2.8% -3.7 pts
1 month-4.7%-6.8% +2.1 pts
3 months+4.6%-7.6% +12.2 pts
6 months+65.8%+0.4% +65.4 pts
1 year+37.3%-9.9% +47.2 pts
2 years+57.5%-13.6% +71.0 pts
3 years+186.1%+14.2% +171.9 pts
5 years+159.0%+27.9% +131.1 pts
92 mutual fund schemes hold about ₹5,026 Cr. Over three months 18 bought more and 24 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Kotak Small Cap Fund4.21%828 +2%
HDFC Small Cap Fund1.67%701 +51%
Nippon India Multi Cap Fund0.79%442 -13%
HSBC Small Cap Fund1.99%380 +13%
Axis Small Cap Fund0.99%313 +0%
Nippon India Pharma Fund2.68%254 -9%
ICICI Pru Flexi Cap Fund0.76%196 -16%
Motilal Oswal Small Cap Fund2.31%188 -27%
ICICI Pru Innovation Fund1.87%147 -5%
Kotak Business Cycle Fund3.19%112 +1%
Edelweiss Small Cap Fund1.43%104 -3%
DSP Healthcare Fund2.44%93 -35%
Axis Large & Mid Cap Fund0.53%92 +2%
Kotak Pioneer Fund2.09%90 -3%
Axis Large & Mid Cap Fund0.53%89 +2%
HDFC Children's Fund(Lock in)0.71%76 +100%
HDFC Pharma and Healthcare Fund2.24%74 -15%
UTI Small Cap Fund1.40%74 +3%
HSBC Large & Mid Cap Fund1.02%61 +100%
Axis Multicap Fund0.54%59 -6%
HSBC Multi Cap Fund0.87%53 +13%
ICICI Pru Bharat Consumption Fund1.47%48 -3%
Aditya Birla SL Balanced Advantage Fund0.38%38 +1%
Bank of India Small Cap Fund1.10%36 -17%
Union Small Cap Fund1.31%35 -9%

Red flags

F-score 5 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹231 Cr +22.9% vs Jun 2025. Net profit ₹53 Cr +35.9%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
Star Imaging and Path Lab Ltd1316.8026.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-09-16Dividend - Rs 2 Per Share
2025-08-29Dividend - Rs 2 Per Share
2024-08-30Dividend - Re 1 Per Share
2023-09-13Annual General Meeting/Dividend - Re 1 Per Share
2022-09-20Dividend - Re 1 Per Share
DateTypeWhat it says
2026-09-26Shareholder meetingVoting results.
2026-09-24Shareholder meetingProceedings of Annual General Meeting held on September 24, 2026
2026-09-11General UpdatesGeneral Updates - Investor Presentation - 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam.
2026-09-11Press ReleaseA press release dated September 11, 2026, titled "100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, As...
2026-09-11Board meeting outcomeOutcome of Board Meeting held on September 11, 2026. (Approval for execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated...
2026-09-02Concall / analyst meetSchedule of meet
2026-09-02AppointmentAppointment of Mr Venkata Naresh Yallapragada as Other of the company w.e.f. September 02, 2026.
2026-09-02Change in ManagementChange in Management
2026-08-26Change in Company Secretary/Resignation of Company Secretary/Compliance Officer
2026-08-26ResignationResignation of Mrs. Naga Vasudha Tadepalli as Company Secretary & Compliance Officer of the company w.e.f. August 26, 2026.
2026-08-26ResignationResignation of Director/KMP/SMP
2026-08-26UpdatesWeblink Letter To Shareholders - As Per Regulation 36(1)(B) OfSEBI (Listing Obligations And Disclosure Requirements) Regulations,2015.
2026-08-26Record DateRecord date for the purpose of Dividend & Meeting is 16-Sep-2026.
2026-08-26Shareholder meetingNotice of Annual General Meeting to be held on September 24, 2026
2026-08-21Change in ManagementChange in Management
2026-08-21Director changeChange in Director(s) of the company.
2026-08-21CessationCessation of Dr. Manjula Anagani as Non- Executive Independent Director of the company w.e.f. August 21, 2026.
2026-08-21Shareholder meetingVoting results.
2026-08-19UpdatesInformation pertaining to AGM, cut-off date for remote e-voting and e-voting at AGM.
2026-08-10Concall / analyst meetTranscript
2026-08-07Concall / analyst meetLink of Recording
2026-08-07UpdatesAudit Committee and Independent Director Report certifying the distribution of proceeds regarding fractional entitlements pursuant to scheme of Amalag...
2026-08-06Investor PresentationInvestor Presentation
2026-08-06Press ReleaseA press release dated August 06, 2026, titled "Press Release on Un-audited results for Quarter ended June 30, 2026".
2026-08-06Board meeting outcomeOutcome of Board Meeting held on August 06, 2026.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Vijaya Diagnostic Centre Ltd?

Vijaya Diagnostic Centre Ltd (VIJAYA) has a market capitalisation of Rs 15,192 Cr. at the 2026-10-01 close.

What is the P/E ratio of Vijaya Diagnostic Centre Ltd?

Vijaya Diagnostic Centre Ltd trades at a P/E of 81.0 on trailing twelve-month profit, at the 2026-10-01 close.

What were Vijaya Diagnostic Centre Ltd's latest quarterly results?

In the Jun 2026 quarter, Vijaya Diagnostic Centre Ltd sales was Rs 231 Cr (+22.9% vs Jun 2025) and net profit was Rs 53 Cr.

What is the 52-week high and low of Vijaya Diagnostic Centre Ltd?

The 52-week high is Rs 1,593.60 and the 52-week low is Rs 848.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03